Home › Funds › Venrock Adviser, LLC › SVRA

Venrock Adviser, LLC position in SVRA

Savara Inc · Health Care

Venrock Adviser, LLC reported holding 14,745,943 shares of SVRA (Savara Inc) in its Q2 2026 13F filing — a position valued at US$90.8M, representing 2.75% of its reported portfolio and ranking #8 among its reported holdings. Venrock Adviser, LLC has disclosed SVRA holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)14.75M sh
Reported value held$90.84M
Portfolio Weight2.75%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's SVRA position evolved

Venrock Adviser, LLC first disclosed a stake in SVRA in Q3 2023 at 7,184,865 shares (US$27.2M). The position peaked in Q2 2026 at 14,745,943 shares, worth US$90.8M. Across 8 filings, Venrock Adviser, LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 14,745,943 shares valued at US$90.8M — an increase of 1,005,568 shares quarter over quarter.. Notable position changes include a 51% trim in Q4 2023 (shares rose 6% over the following quarter), a 173% increase in Q2 2025 (shares rose 57% over the following quarter), a 43% increase in Q3 2025 (shares rose 69% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.18M $27.16M New
Q4 2023 3.50M $16.45M Reduce
Q1 2025 3.26M $9.02M New
Q2 2025 8.88M $20.26M Add
Q3 2025 12.68M $45.27M Add
Q4 2025 13.74M $82.85M Add
Q1 2026 13.74M $75.02M Hold
Q2 2026 14.75M $90.84M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SVRA and 13F data

SVRA (Savara Inc) is a Health Care company. 44 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$83.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SVRA

All SVRA fund holders →

FAQ

How long has Venrock Adviser, LLC held SVRA?

Venrock Adviser, LLC has disclosed SVRA holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is Venrock Adviser, LLC's current position in SVRA?

As of Q2 2026, Venrock Adviser, LLC holds 14.75M shares of SVRA (Savara Inc), valued at $90.84M, representing 2.75% of its reported portfolio and ranking #8.

Has Venrock Adviser, LLC been buying or selling SVRA?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC increased its position in SVRA. The position peaked in Q2 2026 at 14.75M shares.

Which other funds hold SVRA?

Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.